Old Web
English
Sign In
Acemap
>
authorDetail
>
Angela Garcia
Angela Garcia
Janssen-Cilag
Medicine
Oncology
Internal medicine
Abiraterone acetate
Prostate cancer
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical drivers for imaging testing in nonmetastatic castration-resistant prostate cancer: May they be optimized?—Data of “IDENTIFICA” study.
2019
Journal of Clinical Oncology
Eduardo Useros RodrÃguez
Álvaro Juárez
Joaquín Carballido Rodríguez
José Rubio
Alfredo Rodríguez Antolín
Francisco Javier Amores Bermúdez
Antonio Medina González
Miguel Rodrigo
Juan Moreno-Jiménez
Fernando Vázquez
Jacobo Muñoz del Toro
Angela Garcia
José Manuel Cózar Olmo
Show All
Source
Cite
Save
Citations (0)
Evolution of neuropsychiatric adverse events of enzalutamide and abiraterone acetate treatments reported in EudraVigilance in metastatic castration resistant prostate cancer patients.
2018
Journal of Clinical Oncology
Maria Paola Moreno Perez
Miguel Sanchez Iznaola
Angela Garcia
Jacobo Muñoz del Toro
Rafael Parra
Show All
Source
Cite
Save
Citations (0)
Neuropsychiatric adverse events of enzalutamide and abiraterone acetate: Meta-analysis of randomized clinical trials with real world reporting patterns from EudraVigilance.
2018
Journal of Clinical Oncology
Maria Paola Moreno Perez
Miguel Sanchez Iznaola
Angela Garcia
Jacobo Muñoz del Toro
Joaquin Casariego
Paul Robinson
Rafael Parra
Show All
Source
Cite
Save
Citations (1)
Abiraterone acetate with prednisone and cabazitaxel as subsequent treatment after first-line docetaxel in metastatic castrate-resistant prostate cancer (mCRPC): Final efficacy and safety analysis of the CAPRO study.
2017
Journal of Clinical Oncology
Arancha González del Alba
Javier Puente
Núria Sala
Maria Jose Mendez
Alvaro Pinto
Ángel Rodríguez Sánchez
Jose Miguel Cuevas Sanz
Jacobo Muñoz del Toro
Pedro Ruiz
Angela Garcia
Sergio Vázquez Estévez
Show All
Source
Cite
Save
Citations (0)
Predictors of long-term response to abiraterone acetate with prednisone and cabazitaxel after first-line docetaxel in patients with metastastic castration-resistant prostate cancer (mCRPC): Subgroup analysis of a prospective observational study.
2017
Journal of Clinical Oncology
Núria Sala
María José Méndez-Vidal
Alvaro Pinto
Javier Puente
Ángel Rodríguez Sánchez
Jose Miguel Cuevas Sanz
Sergio Vázquez Estévez
Jacobo Muñoz del Toro
Pedro Ruiz
Angela Garcia
Aranzazu Gonzalez del Alba
Show All
Source
Cite
Save
Citations (0)
1